Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study

Fleur Weeber, Geert A. Cirkel, Marlous Hoogstraat, Sander Bins, Christa G.M. Gadellaa-van Hooijdonk, Salo Ooft, Erik van Werkhoven, Stefan M. Willems, Marijn van Stralen, Wouter B. Veldhuis, Nicolle J.M. Besselink, Hugo M. Horlings, Neeltje Steeghs, Maja J. de Jonge, Marlies H.G. Langenberg, Lodewyk F.A. Wessels, Edwin Cuppen, Edwin Cuppen, J.H. Schellens, Stefan SleijferMartijn P. Lolkema, Emile E. Voest

Research output: Contribution to journalArticleScientificpeer-review

7 Citations (Scopus)
25 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study'. Together they form a unique fingerprint.

Medicine & Life Sciences